Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up COVID-19: Information for Patients and Caregivers We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.What you need to know 445 News Items found Finding A Warning Against Using Phone Apps To Detect Skin Cancer Thursday, May 19, 2022 Despite the promise of eventually using artificial intelligence to detect melanoma, much more research and development are needed, MSK experts find. Mission Possible? Revisiting the ‘War on Cancer’ 50 Years Later Wednesday, January 1, 2020 In 1971, Richard Nixon launched a “war on cancer.” It’s still raging. Finding Why Do Certain Chemotherapies Increase the Likelihood of Blood Cancer? Monday, October 26, 2020 New research focuses on clonal hematopoiesis, an age-related blood condition that increases the risk of blood cancer. Joan Massagué Wins Passano Prize Sunday, April 1, 2007 Joan Massagué is the recipient of the 2007 Passano Award for the originality and importance of his work elucidating the mechanism of action for transforming growth factor-beta (TGF-b) signaling. Snapshot The Inner Light: Nanotechnology Reveals Density of Tumors Tuesday, February 23, 2016 MSK <a href="/node/38885">nanotechnology</a> researchers have developed an innovative approach for measuring the permeability of living tumors. In the Clinic A Future Cancer Hospital in NYC to Meet Rising Need Tuesday, September 3, 2024 Learn about MSK's visionary plans for meeting the upcoming surge in cancer cases with state-of-the-art clinical care. Announcement Cancer Biologist Joan Massagué Named Director of the Sloan Kettering Institute Monday, November 25, 2013 Internationally recognized cancer biologist Joan Massagué has been named Director of the Sloan Kettering Institute. He was previously Chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering. Feature The Convergence: Scientists Move toward a New Understanding of Metastatic Cancer Wednesday, February 27, 2019 Through converging lines of research in stem cell biology, tissue regeneration, and immunity, Sloan Kettering Institute scientists are learning what makes metastatic cancer cells tick. In the Lab New Imaging Agent Could Improve Prostate Cancer Diagnosis and Treatment Thursday, November 15, 2012 Researchers at Memorial Sloan Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer. Finding Tumor Mutational Burden Can Help Predict Response to Immunotherapy in Many Different Cancers Thursday, January 17, 2019 Investigators confirmed that people whose tumors have a high tumor mutational burden and were treated with immunotherapy lived longer. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cody's Story: How the MSK Kids Rare Tumor Program Benefited a Teenager With Advanced Kidney Cancer